`
According to Fortune Business Insights, the global structural heart devices market size was valued at USD 14.65 billion in 2025 and is projected to grow from USD 15.59 billion in 2026 to USD 27.16 billion by 2034, exhibiting a CAGR of 7.2% during the forecast period. North America dominated the global structural heart devices market with a market share of 36.52% in 2025.
Structural heart devices are used in minimally invasive procedures to treat abnormalities in heart chambers, valves, and walls. Increasing prevalence of heart diseases, growing geriatric population, and technological advancements in transcatheter procedures are key factors driving adoption. Expanding indications for minimally invasive therapies are also contributing to market growth.
MARKET DYNAMICS
Market Drivers
Growing Prevalence of Heart Disorders
Rising incidence of heart diseases, including congenital defects and valvular conditions, is increasing demand for structural heart devices. Improved diagnostic capabilities and growing geriatric population further support adoption of minimally invasive procedures.
Market Restraints
High Cost of Devices and Procedures
High procedural costs, expensive device materials, and stringent regulatory requirements limit adoption, particularly in emerging markets. Limited reimbursement policies also impact market growth.
Market Opportunities
Increasing Acquisitions and Collaborations
Strategic partnerships and acquisitions among key players are expanding product portfolios and accelerating innovation. Investments in transcatheter valve repair and replacement technologies create growth opportunities.
Market Challenges
Limited Access in Emerging Markets
Limited healthcare infrastructure, shortage of trained professionals, and inadequate reimbursement policies restrict adoption in developing regions.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/structural-heart-devices-market-111600
STRUCTURAL HEART DEVICES MARKET TRENDS
Advancements in Next-Generation Transcatheter Devices
Development of retrievable and repositionable valves, personalized treatment planning, and advanced biomaterials are improving clinical outcomes and expanding patient eligibility.
SEGMENTATION ANALYSIS
By Product
The market is segmented into instruments and accessories. The instruments segment dominates due to rising demand for advanced structural heart devices and increasing product approvals.
By Procedure Type
Procedure types include valve replacement procedures, repair procedures, and structural heart closure procedures. Valve replacement procedures dominate due to increasing prevalence of heart valve defects.
By Indication
Indications include heart valve diseases, congenital heart defects, and others. Heart valve diseases dominate due to high prevalence globally.
By End-User
End-users include hospitals & ASCs, specialty clinics, and others. Hospitals & ASCs dominate due to rising patient admissions and availability of advanced infrastructure.
REGIONAL ANALYSIS
North America
North America dominates the market due to high adoption of transcatheter procedures and advanced healthcare infrastructure.
Europe
Europe is witnessing growth driven by adoption of advanced heart devices and increasing procedural volumes.
Asia Pacific
Asia Pacific is expanding due to improving healthcare infrastructure and rising prevalence of heart diseases.
Latin America
Latin America is experiencing moderate growth due to increasing adoption of advanced cardiac care technologies.
Middle East & Africa
The Middle East & Africa region is witnessing gradual growth supported by expanding cardiac treatment facilities.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/structural-heart-devices-market-111600
COMPETITIVE LANDSCAPE
Key companies operating in the structural heart devices market include:
- Medtronic
- Boston Scientific Corporation
- Abbott
- Edwards Lifesciences Corporation
- Genesis MedTech
- Artivion, Inc.
- Teleflex Incorporated
- Corcym Group
- LivaNova PLC
- JenaValve …and others.
KEY INDUSTRY DEVELOPMENTS
- November 2025: RapidAI received FDA approval for Rapid Aortic solution.
- November 2025: Philips collaborated with Edwards Lifesciences to launch DeviceGuide.
- August 2025: Corcym Group performed robotic aortic valve replacement procedure.
- August 2025: Abbott launched MitraClip G5 and TriClip G5 systems.
- July 2025: JenaValve conducted New York Valves 2025 conference.
REPORT COVERAGE
The structural heart devices market report provides insights into market size, segmentation, regional outlook, and competitive landscape. It highlights technological advancements, increasing cardiovascular disease prevalence, and growth of minimally invasive procedures. These factors are expected to drive market expansion during the forecast period.
`
Top comments (0)